SCHEMBL2002294

SCHEMBL2002294

O=S(=O)(Nc1cc(Cl)cc(Oc2nc3ccc(F)cc3s2)c1)c1ccc(C(F)(F)F)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.49
CYP3A4 P08684 3/20 0.49
FSCN1 Q16658 1/20 0.43
EPHX2 P34913 1/20 0.41
MCL1 Q07820 2/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.39
EPAS1 Q99814 1/20 0.39
RORC P51449 1/20 0.38
SGK1 O00141 1/20 0.38
KDR P35968 1/20 0.38
TEK Q02763 1/20 0.38
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37
CCNA2 P20248 1/20 0.37
CCND1 P24385 1/20 0.37
CDK2 P24941 1/20 0.37
CDK7 P50613 1/20 0.37
CCNH P51946 1/20 0.37
CCNA1 P78396 1/20 0.37
CDK6 Q00534 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1997363 0.94 PPARG (0.49) PPARGCYP3A4MCL1PTGDR2SGK1
SCHEMBL2000221 0.91 PPARG (0.47) PPARGCYP3A4EPHX2MCL1PTGDR2
SCHEMBL2003082 0.91 PPARG (0.47) PPARGCYP3A4EPHX2PTGDR2KDR
SCHEMBL1996053 0.90 PPARG (0.48) PPARGCYP3A4FSCN1
SCHEMBL2001225 0.89 PPARG (0.49) PPARGCYP3A4EPHX2MCL1PTGDR2
SCHEMBL1998403 0.86 PTGDR2 (0.45) PPARGCYP3A4EPHX2PTGDR2CNR1
SCHEMBL2000439 0.85 PPARG (0.51) PPARGCYP3A4EPHX2RORCSGK1
SCHEMBL1996544 0.85 PPARG (0.51) PPARGCYP3A4EPHX2MCL1SGK1
SCHEMBL1994385 0.85 PPARG (0.49) PPARGCYP3A4MCL1SGK1KDR
SCHEMBL1998908 0.84 PPARG (0.49) PPARGCYP3A4MCL1PTGDR2SGK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960408-B2 Quinolinyl and benzothiazolyl modulators AMGEN INC. (US) 2011-06-14 US disclosed
US-7601841-B2 Quinolinyl and benzothiazolyl modulators AMGEN INC. (US) 2009-10-13 US disclosed
US-20090221635-A1 QUINOLINYL AND BENZOTHIAZOLYL MODULATORS AMGEN INC. (US) 2009-09-03 US disclosed
EP-1296967-B1 BENZOTHIAZOLYL PPAR-GAMMA MODULATORS AMGEN INC (US) 2006-05-31 EP disclosed
US-20040176409-A1 Quinolinyl and benzothiazolyl modulators TULARIK INC 2004-09-09 US disclosed
US-20030171399-A1 Quinolinyl and benzothiazolyl modulators TULARIK INC. 2003-09-11 US disclosed
US-6583157-B2 Peroxisome proliferator-activated receptors antagonists; antiinflammatory agents and treating metabolic disorders TULARIK INC. 2003-06-24 US disclosed
US-20020169185-A1 QUINOLINYL AND BENZOTHIAZOLYL MODULATORS AMGEN INC. 2002-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176409-A1 Quinolinyl and benzothiazolyl modulators PPARA, PPARG, PPARD PPARG 2/4885CYP3A4 675/4885FSCN1 4835/4885
US-20030171399-A1 Quinolinyl and benzothiazolyl modulators PPARA, PPARG, PPARD PPARG 2/4885CYP3A4 675/4885FSCN1 4835/4885
US-20020169185-A1 QUINOLINYL AND BENZOTHIAZOLYL MODULATORS PPARA, PPARG, PPARD PPARG 2/4885CYP3A4 675/4885FSCN1 4835/4885
US-20090221635-A1 QUINOLINYL AND BENZOTHIAZOLYL MODULATORS PPARG, PPARA, PPARD PPARG 1/4885CYP3A4 772/4885FSCN1 4826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.